|
Name |
Linoleoyl chloride
|
| Molecular Formula | C18H31ClO | |
| IUPAC Name* |
(9Z,12Z)-octadeca-9,12-dienoyl chloride
|
|
| SMILES |
CCCCC/C=C\C/C=C\CCCCCCCC(=O)Cl
|
|
| InChI |
InChI=1S/C18H31ClO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3/b7-6-,10-9-
|
|
| InChIKey |
FBWMYSQUTZRHAT-HZJYTTRNSA-N
|
|
| Synonyms |
Linoleoyl chloride; Linoleic acid chloride; 7459-33-8; (9Z,12Z)-Octadeca-9,12-dienoyl chloride; Lineoleoyl chloride; LINOLEOYLCHLORIDE; 9,12-Octadecadienoyl chloride, (Z,Z)-; R0E0WI3SP3; NSC-162219; EINECS 231-233-8; MFCD00151403; linolic acid chloride; NSC 162219; UNII-R0E0WI3SP3; SCHEMBL118170; DTXSID30880877; ZINC4556742; Delta 9-12 Octadecadienoyl chloride; Linoleoyl chloride, >=99%, liquid; (Z,Z)-9,12-octadecadienoyl chloride; AKOS024386304; 9,12-Octadecadienoylchloride,(9Z,12Z)-; L0113; (9E,12E)-9,12-Octadecadienoyl chloride #; T72900; W-110221
|
|
| CAS | 7459-33-8 | |
| PubChem CID | 9817754 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 298.9 | ALogp: | 7.6 |
| HBD: | 0 | HBA: | 1 |
| Rotatable Bonds: | 14 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 17.1 | Aromatic Rings: | 0 |
| Heavy Atoms: | 20 | QED Weighted: | 0.203 |
| Caco-2 Permeability: | -4.827 | MDCK Permeability: | 0.00003000 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0 |
| Human Intestinal Absorption (HIA): | 0.022 | 20% Bioavailability (F20%): | 0.999 |
| 30% Bioavailability (F30%): | 1 |
| Blood-Brain-Barrier Penetration (BBB): | 0.516 | Plasma Protein Binding (PPB): | 98.53% |
| Volume Distribution (VD): | 3.093 | Fu: | 0.88% |
| CYP1A2-inhibitor: | 0.437 | CYP1A2-substrate: | 0.455 |
| CYP2C19-inhibitor: | 0.504 | CYP2C19-substrate: | 0.073 |
| CYP2C9-inhibitor: | 0.423 | CYP2C9-substrate: | 0.969 |
| CYP2D6-inhibitor: | 0.326 | CYP2D6-substrate: | 0.912 |
| CYP3A4-inhibitor: | 0.65 | CYP3A4-substrate: | 0.12 |
| Clearance (CL): | 5.123 | Half-life (T1/2): | 0.917 |
| hERG Blockers: | 0.165 | Human Hepatotoxicity (H-HT): | 0.242 |
| Drug-inuced Liver Injury (DILI): | 0.29 | AMES Toxicity: | 0.982 |
| Rat Oral Acute Toxicity: | 0.024 | Maximum Recommended Daily Dose: | 0.104 |
| Skin Sensitization: | 0.964 | Carcinogencity: | 0.897 |
| Eye Corrosion: | 0.98 | Eye Irritation: | 0.964 |
| Respiratory Toxicity: | 0.964 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC001584 | ![]() |
0.839 | D0O1TC | ![]() |
0.714 | ||
| ENC001535 | ![]() |
0.839 | D0UE9X | ![]() |
0.629 | ||
| ENC001660 | ![]() |
0.800 | D0OR6A | ![]() |
0.605 | ||
| ENC001605 | ![]() |
0.800 | D0O1PH | ![]() |
0.557 | ||
| ENC001583 | ![]() |
0.765 | D07ILQ | ![]() |
0.376 | ||
| ENC001699 | ![]() |
0.754 | D09SRR | ![]() |
0.375 | ||
| ENC001714 | ![]() |
0.732 | D0Z5BC | ![]() |
0.368 | ||
| ENC001711 | ![]() |
0.732 | D0XN8C | ![]() |
0.365 | ||
| ENC001845 | ![]() |
0.703 | D05ATI | ![]() |
0.351 | ||
| ENC001589 | ![]() |
0.688 | D0H2YX | ![]() |
0.346 | ||